These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34198109)

  • 1. Care of Parkinson's disease (PD) patients in times of covid-19 pandemic.
    Chattopadhyay S
    Diabetes Metab Syndr; 2021; 15(4):102168. PubMed ID: 34198109
    [No Abstract]   [Full Text] [Related]  

  • 2. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
    Li W; Saweris M; Madhira B
    Am J Ther; 2018; 25(5):e606-e607. PubMed ID: 28731860
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Gordon PH; Frucht SJ
    Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Mizuno Y; Takubo H; Mizuta E; Kuno S
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 77-year-old man with Parkinson's disease and hyperthermia.
    Madigan EJ
    J Emerg Nurs; 2008 Jun; 34(3):229-30. PubMed ID: 18558256
    [No Abstract]   [Full Text] [Related]  

  • 8. Preface: Malignant syndrome in Parkinson's disease.
    Narabayashi H; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S1. PubMed ID: 12735908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parkinson disease--a challenge to the anesthesiologist].
    Jensen SS; Naesh O; Askmark H
    Lakartidningen; 2010 Jun; 107(23):1552-5. PubMed ID: 20617779
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Clarke CE
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):510-1; author reply 511. PubMed ID: 14966183
    [No Abstract]   [Full Text] [Related]  

  • 11. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention and treatment of malignant syndrome in patients with Parkinson's disease].
    Kuno S
    Nihon Rinsho; 2004 Sep; 62(9):1721-4. PubMed ID: 15462391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal pseudo-obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient.
    Shimada J; Sakakibara R; Uchiyama T; Liu Z; Yamamoto T; Ito T; Mori M; Asahina M; Hattori T
    Eur J Neurol; 2006 Mar; 13(3):306-7. PubMed ID: 16618352
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Sato Y; Asoh T; Metoki N; Satoh K
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):574-6. PubMed ID: 12700295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group.
    Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk and course of COVID-19 in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
    Hashimoto T; Tokuda T; Hanyu N; Tabata K; Yanagisawa N
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S25-30. PubMed ID: 12735912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.